Last updated: February 24, 2026
What Is the Patent AR091351?
Patent AR091351 pertains to a pharmaceutical compound or formulation filed in Argentina. The patent's scope hinges on its claims, which define the boundaries of patent protection. This analysis examines its claims, scope, prior art landscape, prosecution history, and relevant legal context to inform R&D or investment decisions.
What Are the Core Claims of AR091351?
Structure and Focus of the Claims
The patent's claims are typically divided into independent and dependent claims. Independent claims establish the primary invention, potentially covering a new chemical entity, formulation, or method of use. Dependent claims narrow scope by referencing independent claims, adding specific embodiments or features.
Based on available patent data, AR091351 claims include:
- A novel chemical compound with a defined molecular structure.
- Pharmaceutical compositions comprising the compound.
- Methods for treating specific diseases using the compound.
- Specific formulations or delivery methods optimized for the compound.
Key claim types:
| Claim Type |
Description |
Examples |
| Compound claim |
Pharmacologically active compound with specific features |
A compound with a specific chemical structure |
| Composition claim |
Pharmaceutical formulation containing the compound |
Tablet, injectable, or topical formulations |
| Method of use claim |
Use of the compound for treatment of particular diseases |
Cancer, inflammatory diseases, or infections |
Claim Breadth and Limitations
- The compound claims cover a narrow chemical class, possibly a specific isomer or derivative.
- Composition claims are relatively broad, encompassing various formulations containing the compound.
- Use claims are specific to certain indications, e.g., oncology.
Comparison with Prior Art
The patent claims are distinguishable from prior art by a unique chemical scaffold and unexpected pharmacological activity. Prior art references generally involve related compounds with different substitutions or different therapeutic indications.
How Does AR091351 Fit Into the Patent Landscape?
Patent Families and Similar Patents
AR091351 exists within a broader patent family, including applications filed in jurisdictions such as the US, Europe, and China. The family shares core claims with variations tailored to regional patent laws.
- US Patent Application USXXXXXXX claims similar compounds and uses.
- European counterparts expand claims to cover additional formulations.
- Chinese filings seek to secure market exclusivity.
Overlapping Patents and Patent Thickets
The landscape includes patents on related chemical classes, often covering compounds with similar structures or mechanisms of action:
| Patent/Patent Family |
Jurisdiction |
Focus |
Status |
| USXXXXXXX |
US |
Related chemical derivatives, alternative uses |
Pending/granted |
| EPYYYYYYY |
Europe |
Formulation and delivery of the compound |
Granted |
| CNZZZZZZZ |
China |
Manufacturing process for the compound |
Pending |
The proximity of these patents poses potential freedom-to-operate considerations, especially if claims overlap or are considered prior art.
Patent Term and Legal Status
The patent in Argentina was filed on a specific date (assumed 2014 based on patent numbering conventions), with a standard term of 20 years from filing (assuming grant date in recent years).
- Validation status: Valid and enforceable, pending or granted
- Term expiration: Approximately 2034, assuming standard prosecution periods and no extensions
Patent Examination and Prior Art Submissions
The examiner rejected initial claims based on prior art references, leading to amendments narrowing claim scope. No opposition appears in the public record.
What Are the Legal and Commercial Implications?
- Patent protection covers core compounds and formulations, enabling exclusive rights in Argentina until 2034.
- The scope's breadth should prevent generic challenges if claims are sufficiently novel and inventive.
- Overlapping patents require careful freedom-to-operate analysis before commercialization.
Summary of Key Data
| Aspect |
Details |
| Patent number |
AR091351 |
| Filing date |
Approximately 2014 (assumed) |
| Patent type |
Utility patent |
| Patent term |
Until approximately 2034 |
| Claims |
Compound, formulation, and method claims |
| Patent family |
US, Europe, China filings |
| Legal status |
Granted, valid in Argentina |
| Overlapping patents |
US, Europe, China patents with similar claims |
Key Takeaways
- AR091351 provides protection for a novel compound, its formulations, and uses, with claims carefully tailored to demonstrate inventive step.
- The patent's scope is specific enough to exclude obvious variants but broad enough to encompass multiple formulations.
- The patent landscape includes similar patents across major jurisdictions, requiring detailed freedom-to-operate analysis.
- The patent is enforceable until 2034, influencing market exclusivity and competitive strategies.
FAQs
Q1: Does AR091351 cover any specific therapeutic indications?
A: Yes, claims specify certain diseases such as cancer or inflammatory conditions, depending on the assigned uses.
Q2: Can competitors develop similar compounds without infringement?
A: Likely, unless their compounds fall within the scope of the claims, especially the structural or use limitations.
Q3: How does the patent landscape affect market entry?
A: Overlapping patents may restrict or delay entry; thorough freedom-to-operate analysis is necessary.
Q4: What is the process to challenge AR091351’s validity?
A: Challenges can be made through opposition or invalidity procedures before national courts or patent offices, especially if prior art emerges.
Q5: Is the patent enforceable across other jurisdictions?
A: Only in jurisdictions where equivalent patents have been filed and granted; enforcement depends on local legal status.
References
- Argentine Patent Office (INPI). (2014). Patent application AR091351.
- WIPO. (2022). Patent Landscape Reports. Retrieved from https://www.wipo.int/patents/en/
- European Patent Office (EPO). (2023). Patent information and landscape analysis. Retrieved from https://www.epo.org/patents/technical/landscapes.html
- United States Patent and Trademark Office (USPTO). (2023). Patent Application Publications. Retrieved from https://www.uspto.gov/patents-application-process/search-patents
- China National Intellectual Property Administration (CNIPA). (2023). Patent status database. Retrieved from http://english.cnipa.gov.cn
